Farmácia/Notícias da Indústria

Estudo inglês mostrou que uma dose de vacina contra a COVID-19 reduz até à metade a transmissão domiciliar – Esta proteção se une ao risco reduzido de uma pessoa vacinada desenvolver infecção sintomática, o qual varia de 60 a 65% após a primeira dose

29 Abr, 2021 | 10:31h

Comunicado de Imprensa: One dose of COVID-19 vaccine can cut household transmission by up to half – Public Health England

Estudo original (preprint): Impact of vaccination on household transmission of SARS-COV-2 in England – Public Health England

Comentários: Covid-19: One dose of vaccine cuts risk of passing on infection by as much as 50%, research shows – The BMJ E Covid: One dose of vaccine halves transmission – study – BBC

Estudo do CDC: Vacinas da Pfizer-BioNTech e Moderna reduzem o risco de hospitalização por Covid-19 em cerca de 64% após a primeira dose e 94% após a segunda dose entre adultos com 65 anos de idade ou mais

29 Abr, 2021 | 10:28h

Effectiveness of Pfizer-BioNTech and Moderna Vaccines Against COVID-19 Among Hospitalized Adults Aged ≥65 Years — United States, January–March 2021 – CDC Morbidity and Mortality Weekly Report

Comentários: Pfizer/Moderna Vaccine Protection: 64% at First Dose, 94% at Second – HealthDay E Pfizer and Moderna vaccines reduce Covid-19 hospitalization risk by 94% among older adults, CDC study says – CNN

Comentário no Twitter

New @CDCMMWR has good news: mRNA COVID-19 vaccines (Pfizer-BioNTech, Moderna) reduced the risk of #COVID19-related hospitalization by 94% among fully vaccinated people 65+. CDC recommends getting a COVID-19 vaccine to prevent severe COVID-19 illness: https://t.co/W4SFuV6wQp. pic.twitter.com/Jf4ph2rl4s

— CDC (@CDCgov) April 28, 2021

China pode se tornar o maior fornecedor de vacinas do mundo pois a Índia está falhando nas entregas globais

29 Abr, 2021 | 10:23h

China May Become World’s Biggest Vaccine Supplier As India Defaults On Global Deliveries – Health Policy Watch

Autoridades regulatórias do Brasil decidem pela não aprovação da vacina do laboratório Gamaleya

29 Abr, 2021 | 10:20h

Brazil Rejects the Gamaleya Vaccine – Science Translational Medicine

Ver também: Russia’s Sputnik V developers reject Brazil’s criticisms – Reuters

Diretriz da AHA: Nos tratamentos de câncer de mama e de próstata que incluem hormonioterapias, é necessário um controle mais rígido do risco cardíaco

29 Abr, 2021 | 10:12h

Impact of Hormonal Therapies for Treatment of Hormone-Dependent Cancers (Breast and Prostate) on the Cardiovascular System: Effects and Modifications: A Scientific Statement From the American Heart Association – Circulation: Genomic and Precision Medicine

Comunicado de Imprensa: Close monitoring for heart risk needed if breast, prostate cancer treatment includes hormones – American Heart Association

Principais tópicos: Impact of Hormonal Therapies for Treatment of Hormone-Dependent Cancers (Breast and Prostate) on the Cardiovascular System – American Heart Association

Comentários: Hormonal Therapy for Breast and Prostate Cancer: Lessons and Opportunities – American Heart Association E Hormonal Based Therapies in the Treatment of Breast and Prostate Cancer – balancing the risks! – American Heart Association E Hormone Cancer Therapies Increase CV Risk: AHA Scientific Statement – TCTMD E Closely Monitor Heart Health in Cancer Patients Who Get Hormonal Therapies: AHA – HealthDay

M-A: Tromboprofilaxia estendida pós-alta hospitalar em pacientes com câncer – A tromboprofilaxia estendida não é associada a taxas reduzidas de eventos tromboembólicos venosos, e está associada a risco aumentado de hemorragia

29 Abr, 2021 | 09:54h

Extended thromboprophylaxis for medically ill patients with cancer: a systemic review and meta-analysis – Blood Advances

M-A: Administração de medicamentos vasopressores via cateter venoso periférico está associada a baixo risco de eventos adversos

29 Abr, 2021 | 09:49h

Adverse events associated with administration of vasopressor medications through a peripheral intravenous catheter: a systematic review and meta-analysis – Critical Care

Metanálise Relacionada: Complication of vasopressor infusion through peripheral venous catheter (Estudo e comentário no Twitter)

Segurança do ácido tranexâmico na artroplastia de quadril e joelho em pacientes de alto risco – este amplo estudo observacional não mostrou risco aumentado de tromboembolismo venoso, infarto do miocárdio, convulsões, acidentes vasculares cerebrais isquêmicos ou ataques isquêmicos transitórios, mesmo se o paciente tem alto risco de base

28 Abr, 2021 | 09:12h

Safety of Tranexamic Acid in Hip and Knee Arthroplasty in High-risk Patients – Anesthesiology (link para o resumo – $ para o texto completo)

Comentários no Twitter

Our study online @_Anesthesiology today: safety of TXA in high-risk pts ➡️data from 500 hospitals shows no increased risks of VTE, MI, seizures, ischemic stroke or TIA. @HipKneeDoc @MountSinaiOrtho 🔗 https://t.co/za7SH8C7rj pic.twitter.com/J8hoW6stNm

— Jashvant Poeran (@jashvant_p) April 16, 2021

Safety of Tranexamic Acid in Hip and Knee Arthroplasty in High-risk Patients @_Anesthesiology

👉TXA in high risk pts is not associated w/ venous thromboembolism, myocardial infarction, seizures, ischemic strokes, or TIAshttps://t.co/DwZe0brJ9L pic.twitter.com/KGcRCftcOl

— Emily Sharpe, MD (@emilysharpe) April 22, 2021

Como o Reino Unido descobriu o primeiro tratamento efetivo da Covid-19 – e salvou milhões de vidas (sobre o estudo RECOVERY e os efeitos da dexametasona)

28 Abr, 2021 | 08:48h

How the UK found the first effective Covid-19 treatment — and saved a million lives – Vox

Relacionado: Covid-19: The Inside Story of the RECOVERY Trial E Covid: The London bus trip that saved maybe a million lives – BBC

ECR: dose reduzida de anticoagulantes orais pode ser uma opção mais segura do que os antagonistas de vitamina K em pacientes em hemodiálise com fibrilação atrial

27 Abr, 2021 | 17:28h

Safety and Efficacy of Vitamin K Antagonists versus Rivaroxaban in Hemodialysis Patients with Atrial Fibrillation: A Multicenter Randomized Controlled Trial – Journal of the American Society of Nephrology (link para o resumo – $ para o texto completo)